XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.25.1

Revenue from contracts with customers (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Summary of disaggregates revenues by major revenue streams | The following table disaggregates Teva’s revenues by major revenue streams. For additional information on disaggregation of revenues, see note 15.
|  | Three months ended March 31, 2025 |
|  | United States |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S.$ in millions) |
Sale of goods |  |  | 1,514 |  |  |  | 1,198 |  |  |  | 553 |  |  |  | 129 |  |  |  | 3,395 |
Licensing arrangements |  |  | 22 |  |  |  | 7 |  |  |  | 6 |  |  |  | 1 |  |  |  | 36 |
Distribution |  |  | 373 |  |  |  | § |  |  |  | 11 |  |  |  | — |  |  |  | 384 |
Other |  |  | 1 |  |  |  | (12 | ) |  |  | 12 |  |  |  | 76 |  |  |  | 76 |
|  | $ | 1,910 |  |  | $ | 1,194 |  |  | $ | 582 |  |  | $ | 206 |  |  | $ | 3,891 |
§ | Represents an amount less than $0.5 million.
|  | Three months ended March 31, 2024 |
|  | United States |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S.$ in millions) |
Sale of goods |  |  | 1,321 |  |  |  | 1,252 |  |  |  | 566 |  |  |  | 128 |  |  |  | 3,267 |
Licensing arrangements |  |  | 23 |  |  |  | 11 |  |  |  | 5 |  |  |  | § |  |  |  | 40 |
Distribution |  |  | 381 |  |  |  | § |  |  |  | 9 |  |  |  | — |  |  |  | 391 |
Other |  |  | § |  |  |  | 9 |  |  |  | 16 |  |  |  | 97 |  |  |  | 121 |
|  | $ | 1,725 |  |  | $ | 1,272 |  |  | $ | 597 |  |  | $ | 225 |  |  | $ | 3,819 |
§ | Represents an amount less than $0.5 million.
Summary of Sales Reserves and Allowances |
|  | Sales Reserves and Allowances |  |  |  |
|  | Reserves included in Accounts Receivable, net |  |  | Rebates |  |  | Medicaid and other governmental allowances |  |  | Chargebacks |  |  | Returns |  |  | Other |  |  | Total reserves included in Sales Reserves and Allowances |  |  | Total |
|  | (U.S.$ in millions) |
Balance at January 1, 2025 |  | $ | 56 |  |  | $ | 1,674 |  |  | $ | 561 |  |  | $ | 936 |  |  | $ | 399 |  |  | $ | 108 |  |  | $ | 3,678 |  |  | $ | 3,734 |
Provisions related to sales made in current year period |  |  | 99 |  |  |  | 1,250 |  |  |  | 219 |  |  |  | 1,988 |  |  |  | 69 |  |  |  | 30 |  |  |  | 3,556 |  |  |  | 3,655 |
Provisions related to sales made in prior periods |  |  | — |  |  |  | (37 | ) |  |  | 9 |  |  |  | (20 | ) |  |  | (3 | ) |  |  | (4 | ) |  |  | (55 | ) |  |  | (55 | )
Credits and payments |  |  | (83 | ) |  |  | (1,224 | ) |  |  | (193 | ) |  |  | (2,035 | ) |  |  | (55 | ) |  |  | (16 | ) |  |  | (3,523 | ) |  |  | (3,606 | )
Translation differences |  |  | — |  |  |  | 19 |  |  |  | 5 |  |  |  | 6 |  |  |  | 2 |  |  |  | 8 |  |  |  | 40 |  |  |  | 40 |
Balance at March 31, 2025 |  | $ | 72 |  |  | $ | 1,682 |  |  | $ | 601 |  |  | $ | 875 |  |  | $ | 412 |  |  | $ | 126 |  |  | $ | 3,696 |  |  | $ | 3,768 |
|  | Sales Reserves and Allowances |  |  |  |
|  | Reserves included in Accounts Receivable, net |  |  | Rebates |  |  | Medicaid and other governmental allowances |  |  | Chargebacks |  |  | Returns |  |  | Other |  |  | Total reserves included in Sales Reserves and Allowances |  |  | Total |
|  | (U.S.$ in millions) |
Balance at January 1, 2024 |  | $ | 61 |  |  | $ | 1,603 |  |  | $ | 540 |  |  | $ | 859 |  |  | $ | 436 |  |  | $ | 97 |  |  | $ | 3,535 |  |  | $ | 3,596 |
Provisions related to sales made in current year period |  |  | 93 |  |  |  | 1,118 |  |  |  | 181 |  |  |  | 1,942 |  |  |  | 73 |  |  |  | 40 |  |  |  | 3,354 |  |  |  | 3,447 |
Provisions related to sales made in prior periods |  |  | — |  |  |  | 10 |  |  |  | 20 |  |  |  | (11 | ) |  |  | (6 | ) |  |  | (1 | ) |  |  | 12 |  |  |  | 12 |
Credits and payments |  |  | (87 | ) |  |  | (1,086 | ) |  |  | (171 | ) |  |  | (1,935 | ) |  |  | (67 | ) |  |  | (18 | ) |  |  | (3,277 | ) |  |  | (3,364 | )
Translation differences |  |  | — |  |  |  | (17 | ) |  |  | (3 | ) |  |  | (5 | ) |  |  | (3 | ) |  |  | (2 | ) |  |  | (30 | ) |  |  | (30 | )
Balance at March 31, 2024 |  | $ | 67 |  |  | $ | 1,628 |  |  | $ | 567 |  |  | $ | 850 |  |  | $ | 433 |  |  | $ | 116 |  |  | $ | 3,594 |  |  | $ | 3,661 |

X
- Definition Tabular disclosure of sales reserves and allowances current. + References No definition available. + Details
Name: | teva_SalesReservesAndAllowancesCurrentTableTextBlock
Namespace Prefix: | teva_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration